Bilaketaren emaitzak - Xinxin Hu

  • Erakusten 1 - 12 emaitzak -- 12
Findu emaitzak
  1. 1
    Overexpression of parkin protects retinal ganglion cells in experimental glaucoma

    Overexpression of parkin protects retinal ganglion cells in experimental glaucoma nork Yi Dai, Xinxin Hu, Xinghuai Sun

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Synthesis and Biological Evaluation of Quinoline Derivatives as a Novel Class of Broad-Spectrum Antibacterial Agents

    Synthesis and Biological Evaluation of Quinoline Derivatives as a Novel Class of Broad-Spectrum Antibacterial Agents nork Haigen Fu, Zhiwen Li, Xinxin Hu, Shuyi Si, Xuefu You, Sheng Tang, Yanxiang Wang, Danqing Song

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Molecular epidemiology of Escherichia coli in bloodstream infections from a general hospital in Ningxia, China, 2022–2023

    Molecular epidemiology of Escherichia coli in bloodstream infections from a general hospital in Ningxia, China, 2022–2023 nork Xinxin Hu, Tao Jia, Lixin Yan, Wei-Zhen Hong, Wen Wang, Liru Wang, Gang� Li, Jia Wei

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    In Vitro Activity of Sodium New Houttuyfonate Alone and in Combination with Oxacillin or Netilmicin against Methicillin-Resistant Staphylococcus aureus

    In Vitro Activity of Sodium New Houttuyfonate Alone and in Combination with Oxacillin or Netilmicin against Methicillin-Resistant Staphylococcus aureus nork Xi Lü, Xinyi Yang, Xue Li, Yun Lu, Zhitao Ren, Longyin Zhao, Xinxin Hu, Jian‐Dong Jiang, Xuefu You

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling

    Inhibition of PHB1/PHB2 suppresses atherosclerotic plaque formation by interrupting PI3K/AKT/mTOR signaling nork Mei Li, Xiao Hu, Xinxin Hu, Fuhua Gao, Ying Cui, Xiaoqing Wei, Yuanhua Qin, Xiaohua An, Ying Zhao, Ying Gao

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094

    Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094 nork Qiang Wang, Yi-Xuan Zhang, Mian Wang, Yi Jiun Tan, Xinxin Hu, Hongwei He, Chunling Xiao, Xuefu You, Yiguang Wang, Maoluo Gan

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China

    Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China nork Lu Nie, Yuemeng Lv, Min Yuan, Xinxin Hu, Tongying Nie, Xinyi Yang, Guoqing Li, Jing Pang, Jingpu Zhang, Congran Li, Xiukun Wang, Xuefu You

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial

    Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trial nork Wei Ou, Ning Li, Bao-Xiao Wang, Tengfei Zhu, Zhilin Shen, Tao Wang, Wuguang Chang, Zenghao Chang, Xinxin Hu, Yue Pu, Lieming Ding, Siyu Wang

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    <i>In Vivo</i> Antibacterial Activity of MRX-I, a New Oxazolidinone

    <i>In Vivo</i> Antibacterial Activity of MRX-I, a New Oxazolidinone nork Congran Li, Qianqian Zhai, Xiukun Wang, Xinxin Hu, Guoqing Li, Weixin Zhang, Jing Pang, Xi Lü, Hong Yuan, M. F. GORDEEV, Letian Chen, Xinyi Yang, Xuefu You

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway

    Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway nork Jia Shi, Tianxi Yu, Kai Song, Shihan Du, Simeng He, Xinxin Hu, Xiangyun Li, Haibo Li, Shuan Dong, Yuan Zhang, Zi-lei Xie, Li Cui, Jianbo Yu

    Argitaratua 2021
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Xiakemycin A, a novel pyranonaphthoquinone antibiotic, produced by the Streptomyces sp. CC8-201 from the soil of a karst cave

    Xiakemycin A, a novel pyranonaphthoquinone antibiotic, produced by the Streptomyces sp. CC8-201 from the soil of a karst cave nork Zhong-Ke Jiang, Lin Guo, Chuan Chen, Shaowei Liu, Lin Zhang, Su-Juan Dai, Qiyang He, Xuefu You, Xinxin Hu, Tuo Li, Wei Jiang, Cheng‐Hang Sun

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Incidental findings during lung low‐dose computed tomography cancer screening in Australia and Canada, 2016–21: a prospective observational study

    Incidental findings during lung low‐dose computed tomography cancer screening in Australia and Canada, 2016–21: a prospective observational study nork Asha Bonney, Diane Pascoe, Mark McCusker, Daniel Steinfort, Henry Marshall, Annette McWilliams, Fraser Brims, Emily Stone, Paul Fogarty, Jeremy D. Silver, Brad Milner, Elizabeth Silverstone, Eugene Hsu, Duy Chinh Nguyen, Christopher Rofe, Cameron White, Xinxin Hu, John R. Mayo, Renelle Myers, Kwun M. Fong, Renée Manser, Stephen Lam

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: